Bad Drugs Are Looking Good
Setup
Ketamine has sometimes been called the “date rape drug” because its sedative properties have enabled sexual assaults — but a groundbreaking study suggests it can also reduce symptoms of depression. Psychedelic drugs, such as psilocybin and LSD, can trigger a schizophrenic episode, but their potential to treat addiction, control post-traumatic stress disorder, and prepare terminally ill patients for death is intriguing. And while marijuana is a controlled substance under federal law, 33 states allow it to be sold for medical uses (and 11 say it’s okay for recreation). Researchers are taking a fresh look at the treatment value of drugs with a reputation for danger and making some surprising discoveries.
Speakers
- 2019 Health
Is there such a thing as a bad drug?
Moderator John Torres, medical correspondent for NBC news, wants to know if the categorization of some drugs as “bad” drugs is warranted, and the panel responds unanimously:
Drugs are never inherently bad, explains Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies. It’s our relationship to drugs and the properties we choose to associate them with that can become problematic. These relationships are not fixed, says Doblin; they can evolve over time as science and society progress.
The science behind marijuana as a treatment for PTSD
Marijuana is is undergoing a complete reinvention from the days of Reefer Madness, and it’s already showing compelling results as a medicine. Mallory Loflin, research scientist at the Department of Veteran Affairs, is pioneering research into how cannabinoids — the specific compounds found in marijuana — could profoundly change how we treat PTSD.
How it works
Rick Doblin follows up Loflin's explanation with a reminder of the difficulties faced by researchers like Loflin in studying “bad” drugs, marijuana included. Because of their dubious reputations, regulatory quagmires often impede the ability of researchers to effectively study these drugs even in controlled environments.
Drugs are a tool, not a panacea
While it’s true that drugs like ketamine and MDMA have produced incredible results when used to treat some mental illnesses, Dennis Charney, dean of the Icahn School of Medicine, and Mallory Loflin want us to remember that they’re almost always used in conjunction with therapy and other treatments:
Claims about drugs can easily outpace research
Somewhat ironically, some “bad” drugs are shedding their notorious reputations and gaining reputations that drastically overstate their safe and effective usage. The panel explains, using examples from their own research, how this can quickly become problematic:
Learn More
Additional Information
Explore More
Economy
Most Americans today would agree that the dream of supporting a family and living a good life on one full time salary is not available to vast numbers of people. Wages have no...
The quest for profits, commitments to social impact, and consumer preference are driving unprecedented change in healthcare as investors pour in money, start-ups and big tech...
Even when the economy is booming and unemployment is low, millions of Americans still face economic hardship. And in the last few years the United States has dealt with supply...
It's been a big year for Patagonia, as it celebrated a 50th anniversary and legally restructured to commit all profits to environmental causes. What can be learned from the co...
How do we sustain growth in a volatile and rapidly changing economy? What’s the best way to foster productivity and fulfillment at work? How will A.I. change the job market? C...
The automotive industry is going through a time of profound transformation, facing internal and external pressure to electrify America’s fleet of personal vehicles. General Mo...
If one dives deeply into the statistics, the American Dream is actually quite alive and well. In his provocative book, The Myth of American Inequality, former U.S. senator Phi...
How can we unlock the power of entrepreneurship to widen access to health care, close gender disparity, and increase prosperity in the global South? Hear from expert voices an...
In this new Aspen Ideas format, all attendees gather each morning to kick off the day by exploring a current issue of deep complexity. For decades, American policy regardin...
Alongside climate adaptation, wealth inequality is one of America’s most urgent problems. Learn from a diverse group of innovators about their contributions and commitments to...
Philosophical and religious teachings regarding wealth can feel both archaic and strangely relevant to our age of economic upheaval. How can we reconcile these ideas about wea...
The American economy motors on, with unemployment near record lows, incomes outpacing rising prices, the debt default averted, the stock market showing surprising strength, an...
Economic uncertainty continues its reign of confusion, vexing financial leaders, regulators, and consumers with worrisome inflation and unpredictable markets. Experts weigh in...
Creating a meaningful life with work that’s fulfilling is not for the faint-hearted in a post-pandemic world. How can we navigate these choppy waters with grace, humor, and wi...
Despite high demand for nutritious foods, many Americans experience gaps, challenges, and barriers when it comes to access and agency over their nutrition. How can the public...
Digital skills open doors to jobs in tech, media, and across all industries. Connecting diverse students and workers with the education and training needed for the 92% of toda...
How are business leaders navigating rising expectations from employees, investors, customers, and communities in a fractured political environment, while progressing on the lo...
Plenty of organizations find success without codifying a specific purpose. Why, then, do more and more CEOs find purpose to be so valuable for leading in today’s increasingly...
The impact of A.I. on the job market is debatable, as it has the potential to both automate tasks and displace workers but also the potential to create new economic opportunit...
In a time of historically low trust in leaders and institutions, how can leaders build trust across lines of difference, depolarize solutions, and not live in fear of cancel c...